참고문헌
- M'Koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33-47. https://doi.org/10.4137/CGast.S12731
- Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. https://doi.org/10.1056/NEJMra020831
- Jo-Watanabe A, Okuno T, Yokomizo T. The role of leukotrienes as potential therapeutic targets in allergic disorders. Int J Mol Sci. 2019;20:3580. https://doi.org/10.3390/ijms20143580
- Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350-359. https://doi.org/10.7326/0003-4819-156-5-201203060-00007
- Laine L, Smith R, Min K, Chen C, Dubois RW. Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2006;24:751-767. https://doi.org/10.1111/j.1365-2036.2006.03043.x
- Wallace JL, Syer S, Denou E, de Palma G, Vong L, McKnight W, Jury J, Bolla M, Bercik P, Collins SM, Verdu E, Ongini E. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011;141:1314-1322, 1322. e1-e5. https://doi.org/10.1053/j.gastro.2011.06.075
- Satoh H, Amagase K, Takeuchi K. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility. J Pharmacol Exp Ther. 2012;343:270-277. https://doi.org/10.1124/jpet.112.197475
- Lanas A, Garcia-Rodriguez LA, Polo-Tomas M, Ponce M, AlonsoAbreu I, Perez-Aisa MA, Perez-Gisbert J, Bujanda L, Castro M, Munoz M, Rodrigo L, Calvet X, Del-Pino D, Garcia S. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104:1633-1641. https://doi.org/10.1038/ajg.2009.164
- Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother. 2004;5:1347-1357. https://doi.org/10.1517/14656566.5.6.1347
- Lee OY, Kang DH, Lee DH, Chung IK, Jang JY, Kim JI, Cho JW, Rew JS, Lee KM, Kim KO, Choi MG, Lee SW, Lee ST, Kim TO, Shin YW, Seol SY. A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment. Arch Pharm Res. 2014;37:1308-1316. https://doi.org/10.1007/s12272-014-0408-3
- Huh K, Kwon TH, Shin US, Kim WB, Ahn BO, Oh TY, Kim JA. Inhibitory effects of DA-9601 on ethanol-induced gastrohemorrhagic lesions and gastric xanthine oxidase activity in rats. J Ethnopharmacol. 2003;88:269-273. https://doi.org/10.1016/S0378-8741(03)00235-6
- Oh TY, Lee JS, Ahn BO, Cho H, Kim WB, Kim YB, Surh YJ, Cho SW, Lee KM, Hahm KB. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut. 2001;49:364-371. https://doi.org/10.1136/gut.49.3.364
- Boynton CS, Dick CF, Mayor GH. NSAIDs: an overview. J Clin Pharmacol. 1988;28:512-517. https://doi.org/10.1002/j.1552-4604.1988.tb03170.x
- Scheiman JM. The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage. Arthritis Res Ther. 2013;15(Suppl 3):S5. https://doi.org/10.1186/ar4177
- Tai FWD, McAlindon ME. NSAIDs and the small bowel. Curr Opin Gastroenterol. 2018;34:175-182. https://doi.org/10.1097/MOG.0000000000000427
- Park SC, Chun HJ, Kang CD, Sul D. Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury. World J Gastroenterol. 2011;17:4647-4653. https://doi.org/10.3748/wjg.v17.i42.4647
- Oh TY, Ryu BK, Ko JI, Ahn BO, Kim SH, Kim WB, Lee EB, Jin JH, Hahm KB. Protective effect of DA-9601, an extract of Artemisiae Herba, against naproxen-induced gastric damage in arthritic rats. Arch Pharm Res. 1997;20:414-419. https://doi.org/10.1007/BF02973932
- Kim HS, Kundu JK, Lee JS, Oh TY, Na HK, Surh YJ. Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis. Nutr Cancer. 2008;60 Suppl 1:90-97. https://doi.org/10.1080/01635580802404170
- Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am. 1996;6:489-504. https://doi.org/10.1016/S1052-5157(18)30351-9
- Blackler RW, Gemici B, Manko A, Wallace JL. NSAID-gastroenteropathy: new aspects of pathogenesis and prevention. Curr Opin Pharmacol. 2014;19:11-16. https://doi.org/10.1016/j.coph.2014.05.008
- Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. J Pain Res. 2018;11:361-374. https://doi.org/10.2147/JPR.S156938
- Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. https://doi.org/10.1038/sigtrans.2017.23
- Muzes G, Molnar B, Tulassay Z, Sipos F. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol. 2012;18:5848-5861. https://doi.org/10.3748/wjg.v18.i41.5848
- Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-1767. https://doi.org/10.1053/j.gastro.2011.02.016
- Kuwabara T, Ishikawa F, Kondo M, Kakiuchi T. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017;2017:3908061. https://doi.org/10.1155/2017/3908061
- Chamoun-Emanuelli AM, Bryan LK, Cohen ND, Tetrault TL, Szule JA, Barhoumi R, Whitfield-Cargile CM. NSAIDs disrupt intestinal homeostasis by suppressing macroautophagy in intestinal epithelial cells. Sci Rep. 2019;9:14534. https://doi.org/10.1038/s41598-019-51067-2
- Song EM, Jung SA, Lee JS, Kim SE, Shim KN, Jung HK, Yoo K, Park HY. Benzoxazole derivative B-98 ameliorates dextran sulfate sodium-induced acute murine colitis and the change of T cell profiles in acute murine colitis model. Korean J Gastroenterol. 2013;62:33-41. https://doi.org/10.4166/kjg.2013.62.1.33
- Yamada A, Arakaki R, Saito M, Tsunematsu T, Kudo Y, Ishimaru N. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2016;22:2195-2205. https://doi.org/10.3748/wjg.v22.i7.2195
- Catana CS, Berindan Neagoe I, Cozma V, Magdas C, Tabaran F, Dumitrascu DL. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2015;21:5823-5830. https://doi.org/10.3748/wjg.v21.i19.5823
- Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16:26-42. https://doi.org/10.5217/ir.2018.16.1.26